Skip to main content
. 2013 May;57(5):2295–2303. doi: 10.1128/AAC.00175-13

Table 1.

Antimicrobial activity of selected peptides (library PL-D)

Sequence MIC (μM)a
M. tuberculosis M. smegmatis P. aeruginosa E. coli S. enterica serovar Typhimurium C. albicans S. epidermidis S. aureus E. faecalis
WKWLKKWIK 1.1 1.9 2.9 5.8 11.5 5.8 0.7–0.3 0.7 11.5
ILRWKWRWWRWRR 2.4 2.4 5.7 1.4 2.9 5.7 0.7 0.7 2.9
ILPWKWRWWKWRR 2.6 2.2 5.7 1.4 5.7 2.9 0.7 0.7 2.9
RWRRKWWWW 2.8 5.7 11.2 1.4 2.8 5.6 0.7 0.7 2.8
WRKFWKYLK 3.0 1.5 6.0 0.8 6.0 3.0 0.8 0.8 6.0
KRWWKWWRR 3.1 4.9 11.1 2.8 5.6 5.6 0.7 0.7 11.1
RRWWKWWWR 3.6 4.8 5.4 2.7 2.7 5.4 0.7 0.7 5.4
KIWWWWRKR 4.1 5.4 42.3 5.3 10.6 10.6 1.3 1.3 10.6
RLWWWWRRK 4.1 2.4 16.6 4.1 8.3 4.1 0.5 2.1 4.1
KWKWWWRKI 4.2 6.4 4.6 4.6 4.6 4.6 1.2 1.2 4.6
RIRRWKFRW 4.3 1.4 42.6 5.3 5.3 21.3 1.3 1.3 5.3
RLKRWWKFL 4.5 3.0 9.8 1.2 4.9 9.8 1.2 2.4 9.8
RWWRWRKWW 4.6 4.6 10.3 2.6 5.2 2.6 0.6 0.6 5.2
KRWWWWRFR 5.2 5.2 46.9 2.9 5.9 5.9 0.7 0.7 11.7
KRWWRKWWR 5.3 5.3 43.2 2.7 5.4 5.4 0.7 0.7 10.8
RRWWRWVVW 5.6 11.4 2.6 0.7 2.6 10.4 0.7 1.3 2.6
WFKMRWWGR 5.9 2.2 46.1 5.8 23.1 11.5 2.9 2.9 11.5
KFKWWRMLI 6.1 15.3 4.6 0.6 2.3 4.6 0.6 1.2 2.3
FIKWKFRWWKWRK 7.4 3.7 6.0 1.5 1.5 3.0 0.7 0.7 1.5
RIKRWWWWR 7.8 4.6 86.3 2.7 2.7 5.4 1.3 1.3 10.8
RWRWWWRVY 8.0 6.7 13.2 1.6 3.3 13.2 1.6 3.3 3.3
HQFRFRFRVRRK 8.2 4.1 32.0 8.0 4.0 8.0 1.0 2.0 16.0
LKRRWKWWI 8.8 5.1 19.1 2.4 9.6 19.1 1.2 2.4 9.6
RRRIKIRWY 8.9 1.5 38.2 0.6 9.5 19.1 1.2 2.4 9.5
RLWWKIWLK 9.0 3.8 22.5 2.8 11.3 5.6 1.4 1.4 5.6
KRRWRIWLV 9.1 2.7 3.0 3.0 3.0 12.0 1.5–0.7 1.5 3.0
FFIYVWRRR 11.9 1.3 15.3 3.8 7.6 7.6 1.0 1.9 3.8
IRMRIRVLL 13.7 0.3 16.0 2.0 4.0 16.0 2.0 4.0 16.0
RWWRKIWKW 16.6 8.3 2.2 8.8 8.8 4.4 1.1 2.2 4.4
LRFILWWKR 17.0 4.2 25.7 3.2 6.4 6.4 1.6 1.6 6.4
RWWIRIRWH 17.0 1.6 10.7 1.3 2.7 10.7 1.3 1.3 2.7
RRRWWKLMM 17.6 2.2 11.0 2.7 11.0 21.9 2.7–1.4 5.5 21.9
LRRWIRIRW 17.7 2.2 21.4 0.7 5.4 10.7 1.3–0.6 1.3 5.4
RKFRWWVIR 17.8 3.7 21.9 2.7.0 5.5 21.9 1.4–0.5 1.4 10.9
WKIVFWWRR 23.3 4.4 21.9 1.4 2.7 5.5 0.7 1.4 2.7
RQRRVVIWW 24.7 1.9 10.7 1.3 5.3 21.4 1.3 2.7 5.3
RRWRVIVKW 24.7 2.3 2.7 1.3 2.7 5.4 0.7 1.3 2.7
RRWKIVVIRWRR 24.8 6.2 5.6 1.4 2.8 11.1 0.3 0.7 1.4
RLWRIVVIRVKR 25.9 4.3 7.1 1.8 3.5 7.1 0.4 0.9 1.8
RLRRIVVIRVFR 29.8 5.0 8.0 4.0 4. 16.0 0.5 1.0 2.0
VRLRIRVRVIRK 30.1 1.6 2.0 2.0 2.0 8.0 1.0 1.0 4.0
RRYHWRIYI 33.2 16.6 12.5 1.6 6.3 12.5 3.1 3.1 12.5
RKWKIKWYW 34.5 2.9 5.2 0.7 2.6 10.5 1.3 2.6 5.2
YRLRVKWKW 36.0 1.5 14.3 3.6 7.1 3.6 0.9 1.8 7.1
WKWRVRVTI 51.5 0.8 5.4 1.3 2.7 10.8 1.3 2.7 2.7
RTKKWIVWI 78.1 9.8 11.6 1.4 5.8 23.1 2.9 5.8 11.6
NWRKLYRRK 109.3 38.3 >86.5 86.5 >86.5 86.5 43.3 86.5 >86.5
YKFRWRIYI 130.0 16.2 >92.8 2.9 >92.8 >92.8 1.4 2.9 2.9
KRKKRFKWW 141.0 8.8 165–80.3 20.6 20.6 41.2 2.6 2.6 10.3
Median 9.0 4.1 11.2 2.6 5.3 8.0 1.2 1.4 5.3
a

In vitro assays for M. tuberculosis and M. smegmatis are described in Materials and Methods and presented as MIC90 values. For all others, the MIC was defined by no visual growth. Peptides originating from PL-C are shown in bold.